- Home
- AXP vs NVS Comparison
AXP vs NVS Comparison
Compare AXP & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXP
- NVS
- Stock Information
- Founded
- AXP 1850
- NVS 1895
- Country
- AXP United States
- NVS Switzerland
- Employees
- AXP N/A
- NVS N/A
- Industry
- AXP Finance: Consumer Services
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- AXP Finance
- NVS Health Care
- Exchange
- AXP Nasdaq
- NVS Nasdaq
- Market Cap
- AXP 192.7B
- NVS 230.5B
- IPO Year
- AXP N/A
- NVS 1991
- Fundamental
- Price
- AXP $298.74
- NVS $97.08
- Analyst Decision
- AXP Hold
- NVS Hold
- Analyst Count
- AXP 22
- NVS 6
- Target Price
- AXP $265.40
- NVS $121.25
- AVG Volume (30 Days)
- AXP 2.4M
- NVS 1.1M
- Earning Date
- AXP 01-24-2025
- NVS 01-31-2025
- Dividend Yield
- AXP 0.94%
- NVS 3.89%
- EPS Growth
- AXP 27.35
- NVS 130.53
- EPS
- AXP 13.58
- NVS 8.58
- Revenue
- AXP $59,239,000,000.00
- NVS $49,940,000,000.00
- Revenue This Year
- AXP N/A
- NVS $10.04
- Revenue Next Year
- AXP $7.99
- NVS $4.55
- P/E Ratio
- AXP $22.00
- NVS $11.02
- Revenue Growth
- AXP 8.94
- NVS 8.92
- 52 Week Low
- AXP $177.81
- NVS $92.35
- 52 Week High
- AXP $307.82
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- AXP 53.11
- NVS 27.93
- Support Level
- AXP $286.43
- NVS $97.69
- Resistance Level
- AXP $303.59
- NVS $99.67
- Average True Range (ATR)
- AXP 5.94
- NVS 1.01
- MACD
- AXP -1.72
- NVS -0.18
- Stochastic Oscillator
- AXP 66.04
- NVS 10.97
About AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. Since 2018, it has operated in three segments: global consumer services, global commercial services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.